Home > Research > Publications & Outputs > Improving colposcopic accuracy for cervical pre...

Links

Text available via DOI:

View graph of relations

Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China. / Wei, B.; Zhang, B.; Xue, P. et al.
In: BMC Cancer, Vol. 22, No. 1, 388, 10.04.2022.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Wei, B, Zhang, B, Xue, P, Seery, S, Wang, J, Li, Q, Jiang, Y & Qiao, Y 2022, 'Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China', BMC Cancer, vol. 22, no. 1, 388. https://doi.org/10.1186/s12885-022-09498-0

APA

Wei, B., Zhang, B., Xue, P., Seery, S., Wang, J., Li, Q., Jiang, Y., & Qiao, Y. (2022). Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China. BMC Cancer, 22(1), Article 388. https://doi.org/10.1186/s12885-022-09498-0

Vancouver

Wei B, Zhang B, Xue P, Seery S, Wang J, Li Q et al. Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China. BMC Cancer. 2022 Apr 10;22(1):388. doi: 10.1186/s12885-022-09498-0

Author

Wei, B. ; Zhang, B. ; Xue, P. et al. / Improving colposcopic accuracy for cervical precancer detection : a retrospective multicenter study in China. In: BMC Cancer. 2022 ; Vol. 22, No. 1.

Bibtex

@article{cb70dfe6b02d480a99a9267d2fdbd0a3,
title = "Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China",
abstract = "Background: Colposcopy alone can result in misidentification of high-grade squamous intraepithelial or worse lesions (HSIL +), especially for women with Type 3 transformation zone (TZ) lesions, where colposcopic assessment is particularly imprecise. This study aimed to improve HSIL + case identification by supplementing referral screening results to colposcopic findings. Methods: This is an observational multicenter study of 2,417 women, referred to colposcopy after receiving cervical cancer screening results. Logistic regression analysis was conducted under uni- and multivariate models to identify factors which could be used to improve HSIL + case identification. Histological diagnosis was established as the gold standard and is used to assess accuracy, sensitivity, and specificity, as well as to incrementally improve colposcopy. Results: Multivariate analysis highlighted age, TZ types, referral screening, and colposcopists{\textquoteright} skills as independent factors. Across this sample population, diagnostic accuracies for detecting HSIL + increased from 72.9% (95%CI 71.1–74.7%) for colposcopy alone to 82.1% (95%CI 80.6–83.6%) after supplementing colposcopy with screening results. A significant increase in colposcopic accuracy was observed across all subgroups. Although, the highest increase was observed in women with a TZ3 lesion, and for those diagnosed by junior colposcopists. Conclusion: It appears possible to supplement colposcopic examinations with screening results to improve HSIL + detection, especially for women with TZ3 lesions. It may also be possible to improve junior colposcopists{\textquoteright} diagnoses although, further psychological research is necessary. We need to understand how levels of uncertainty influence diagnostic decisions and what the concept of “experience” actually is and what it means for colposcopic practice. ",
keywords = "Accuracy, Cervical cancer, Colposcopy, High-grade squamous intraepithelial lesion",
author = "B. Wei and B. Zhang and P. Xue and S. Seery and J. Wang and Q. Li and Y. Jiang and Y. Qiao",
year = "2022",
month = apr,
day = "10",
doi = "10.1186/s12885-022-09498-0",
language = "English",
volume = "22",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - Improving colposcopic accuracy for cervical precancer detection

T2 - a retrospective multicenter study in China

AU - Wei, B.

AU - Zhang, B.

AU - Xue, P.

AU - Seery, S.

AU - Wang, J.

AU - Li, Q.

AU - Jiang, Y.

AU - Qiao, Y.

PY - 2022/4/10

Y1 - 2022/4/10

N2 - Background: Colposcopy alone can result in misidentification of high-grade squamous intraepithelial or worse lesions (HSIL +), especially for women with Type 3 transformation zone (TZ) lesions, where colposcopic assessment is particularly imprecise. This study aimed to improve HSIL + case identification by supplementing referral screening results to colposcopic findings. Methods: This is an observational multicenter study of 2,417 women, referred to colposcopy after receiving cervical cancer screening results. Logistic regression analysis was conducted under uni- and multivariate models to identify factors which could be used to improve HSIL + case identification. Histological diagnosis was established as the gold standard and is used to assess accuracy, sensitivity, and specificity, as well as to incrementally improve colposcopy. Results: Multivariate analysis highlighted age, TZ types, referral screening, and colposcopists’ skills as independent factors. Across this sample population, diagnostic accuracies for detecting HSIL + increased from 72.9% (95%CI 71.1–74.7%) for colposcopy alone to 82.1% (95%CI 80.6–83.6%) after supplementing colposcopy with screening results. A significant increase in colposcopic accuracy was observed across all subgroups. Although, the highest increase was observed in women with a TZ3 lesion, and for those diagnosed by junior colposcopists. Conclusion: It appears possible to supplement colposcopic examinations with screening results to improve HSIL + detection, especially for women with TZ3 lesions. It may also be possible to improve junior colposcopists’ diagnoses although, further psychological research is necessary. We need to understand how levels of uncertainty influence diagnostic decisions and what the concept of “experience” actually is and what it means for colposcopic practice.

AB - Background: Colposcopy alone can result in misidentification of high-grade squamous intraepithelial or worse lesions (HSIL +), especially for women with Type 3 transformation zone (TZ) lesions, where colposcopic assessment is particularly imprecise. This study aimed to improve HSIL + case identification by supplementing referral screening results to colposcopic findings. Methods: This is an observational multicenter study of 2,417 women, referred to colposcopy after receiving cervical cancer screening results. Logistic regression analysis was conducted under uni- and multivariate models to identify factors which could be used to improve HSIL + case identification. Histological diagnosis was established as the gold standard and is used to assess accuracy, sensitivity, and specificity, as well as to incrementally improve colposcopy. Results: Multivariate analysis highlighted age, TZ types, referral screening, and colposcopists’ skills as independent factors. Across this sample population, diagnostic accuracies for detecting HSIL + increased from 72.9% (95%CI 71.1–74.7%) for colposcopy alone to 82.1% (95%CI 80.6–83.6%) after supplementing colposcopy with screening results. A significant increase in colposcopic accuracy was observed across all subgroups. Although, the highest increase was observed in women with a TZ3 lesion, and for those diagnosed by junior colposcopists. Conclusion: It appears possible to supplement colposcopic examinations with screening results to improve HSIL + detection, especially for women with TZ3 lesions. It may also be possible to improve junior colposcopists’ diagnoses although, further psychological research is necessary. We need to understand how levels of uncertainty influence diagnostic decisions and what the concept of “experience” actually is and what it means for colposcopic practice.

KW - Accuracy

KW - Cervical cancer

KW - Colposcopy

KW - High-grade squamous intraepithelial lesion

U2 - 10.1186/s12885-022-09498-0

DO - 10.1186/s12885-022-09498-0

M3 - Journal article

VL - 22

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 388

ER -